Font Size:
a
A
A
Keyword [sodium glucose cotransporter 2]
Result: 21 - 40 | Page: 2 of 3
21.
Clinical Observation Of Sodium-glucose Cotransporter 2 Inhibitor In The Treatment Of Type 2 Diabetes Mellitus With Chronic Kidney Disease
22.
Effect Of Ectopic Fat Deposition On Renal Tubule Glucose Transporter And Its Mechanism
23.
The Effect Of SGLT2 Inhibitor On Blood Lipid Profile In Adult Patients With Type 2 Diabetes Mellitus: A Meta-analysis
24.
The Effect Of Sodium-glucose Co-transporter 2 Inhibitiors On Albuminuria In Patients With Type 2 Diabetes: A Systematic Review
25.
Basic Study On The Application Effect Of SGLT2i-Cagliazin On Nephrotic Syndrome
26.
Effects And Mechanisms Of Soluble Epoxide Hydrolase Inhibitor TPPU On Improving Diabetes And Hypertension
27.
Efficacy And Prognosis Analysis Of Sodium-glucose Cotransporter-2 Inhibitor In The Treatment Of Heart Failure With Reduced Ejection Fraction
28.
Effects Of SGLT-2 Inhibitors On The Prognosis Of Patients With Heart Failure With Reduced Ejection Fraction:
29.
Study On The Efficacy Of SGLT2 Inhibitors In The Treatment Of Type 2 Diabetes Mellitus Complicated With NAFLD
30.
The Effect Of Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin On Cardiac Function In A Normoglycemic Rabbit Model Of Chronic Heart Failure And Its Mechanism
31.
Effects Of Canagliflozin On Atherosclerosis And Hepatic Steatosis In ApoE
-/-
Mice:Mechanisms Associated With ASS1/AMPK Pathway
32.
The Effect And Mechanism Of Intermedin On Sodium Glucose Cotransporter 2 Expression And Function Induced By High Sodium
33.
Effects Of Sodium-Glucose Cotransporter-2 Inhibitors On Renal Function In Patients With Type 2 Diabetes Mellitus And Chronic Kidney Disease: A Network Meta-Analysis
34.
A Retrospective Study Of Laboratory Indicators And Hypoglyceic Drug Use Correlationin Patients With Type 2 Diabetes Mellitus
35.
Study On The Clinical Efficacy Of HFrEF Patients With Renal Insufficiency In Dapagliflozin
36.
Dapagliflozin In Patients With Chronic Heart Failure:a Systematic Review And Meta-analysis
37.
Effects Of SGLT-2i On HbA1c And BP In Patients With Type 2 Diabetes Mellitus And Hypertension In Xining Area
38.
Influence Of Dapagliflozin On Blood Pressure And Left Ventricular Hypertrophy In Patients With Type 2 Diabetes And Hypertension
39.
The Effects Of SGLT2 Inhibitors On Cardiac Function In Patients With Heart Failure With Preserved Ejection Fraction:A Meta-analysis
40.
Effects Of SGLT-2 Inhibitors On Body Compositions In Type 2 Diabetes Mellitus:Meta-analysis
<<First
<Prev
Next>
Last>>
Jump to